Emend

In the US, Emend (aprepitant systemic) is a member of the drug class miscellaneous antiemetics and is used to treat Nausea/Vomiting - Chemotherapy Induced and Nausea/Vomiting - Postoperative.

US matches:

• Emend


• Emend for Injection pimozide


• Emend 2-Day


• Emend 3-Day


• Emend for Injection


• Emend Intravenous


• Emend Injection

UK matches:

• EMEND 80mg, 125mg hard Capsules
• EMEND 80mg, 125mg hard Capsules (SPC)

Ingredient matches for Emend

Aprepitant

Aprepitant is reported as an ingredient of Emend in the following countries:

• Argentina


• Aruba


• Australia


• Austria


• Bahamas


• Barbados


• Belgium


• Belize


• Brazil


• Bulgaria


• Canada


• Cayman Islands


• Chile


• Croatia (Hrvatska)


• Czech Republic


• Denmark


• Dominican Republic


• Finland


• France


• Georgia


• Germany


• Greece


• Hong Kong


• Hungary


• Iceland


• Ireland


• Italy


• Jamaica


• Luxembourg


• Malaysia


• Mexico


• Netherlands


• Netherlands Antilles


• New Zealand


• Norway


• Peru


• Portugal


• Russian Federation


• Singapore


• Slovenia


• South Africa


• Spain


• Sweden


• Switzerland


• Taiwan


• Thailand


• Trinidad & Tobago


• Turkey


• United Kingdom


• United States


• Venezuela

International Drug Name Search

Glossary

SPC	Summary of Product Characteristics (UK)

Click for further information on drug naming conventions and International Nonproprietary Names.